Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure.
暂无分享,去创建一个
Shingo Kawasaki | Tatsuya Kawasaki | Tadaaki Kamitani | H. Matsubara | H. Sugihara | S. Asada | A. Azuma | Mitsuyoshi Hadase | Akihiro Azuma | Kan Zen | Satoshi Asada | Hiroki Sugihara | Hiroaki Matsubara | T. Kawasaki | M. Hadase | K. Zen | S. Kawasaki | T. Kamitani
[1] T. Yandle,et al. Biochemistry of natriuretic peptides , 1994, Journal of internal medicine.
[2] G. Naccarelli,et al. Congestive heart failure with normal systolic function. , 1984, The American journal of cardiology.
[3] A. Tamura,et al. Effect of preinfarction angina on heart rate variability in the early phase of the first anterior wall acute myocardial infarction. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[4] M. Turiel,et al. Power Spectral Analysis of Heart Rate and Arterial Pressure Variabilities as a Marker of Sympatho‐Vagal Interaction in Man and Conscious Dog , 1986, Circulation research.
[5] K Koizumi,et al. Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic fluctuations. , 1985, Journal of the autonomic nervous system.
[6] D. Ferguson,et al. Effects of heart failure on baroreflex control of sympathetic neural activity. , 1992, The American journal of cardiology.
[7] D. Fukai,et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.
[8] J. Fleiss,et al. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. , 1990, The American journal of cardiology.
[9] A. DeMaria,et al. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction , 2002 .
[10] S. Yusuf,et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.
[11] Kiyoshi Nakazawa,et al. Autonomic imbalance as a property of symptomatic Brugada syndrome. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[12] R. Tarazi,et al. Assessment of parasympathetic control of heart rate by a noninvasive method. , 1984, The American journal of physiology.
[13] P. Sleight,et al. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. , 1996, Cardiovascular research.
[14] J. Izzo,et al. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. , 1981, Life sciences.
[15] R Colombo,et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. , 1999, Circulation.
[16] I. Yamaguchi,et al. Effects of linear ablation at the isthmus between the tricuspid annulus and inferior vena cava for atrial flutter on autonomic nervous activity: analysis of heart rate variability. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[17] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[18] R. Prescott,et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.
[19] M. Packer. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system. , 1988, Postgraduate medicine.
[20] W. Stevenson,et al. Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure. , 1994, Journal of the American College of Cardiology.
[21] J. Burnett,et al. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. , 1997, The American journal of physiology.
[22] J. Fleiss,et al. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. , 1993, Journal of the American College of Cardiology.
[23] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[24] T Seppänen,et al. Impaired low-frequency oscillations of heart rate in patients with prior acute myocardial infarction and life-threatening arrhythmias. , 1995, The American journal of cardiology.
[25] Richard J. Cohen,et al. Estimation of heart rate power spectrum bands from real-world data: dealing with ectopic beats and noisy data , 1988, Proceedings. Computers in Cardiology 1988.
[26] R. Cohen,et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.
[27] G. Habib,et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. , 2002, Circulation.
[28] A. Tamura,et al. Relationship between heart rate variability and left ventricular remodeling after reperfused first anterior wall acute myocardial infarction. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[29] A. Malliani,et al. Cardiovascular Neural Regulation Explored in the Frequency Domain , 1991, Circulation.
[30] G D Pinna,et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. , 1997, Circulation.
[31] H. Sostman,et al. Intact systolic left ventricular function in clinical congestive heart failure. , 1985, The American journal of cardiology.
[32] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[33] A. Richards,et al. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.
[34] M. Naughton,et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. , 1995, American journal of respiratory and critical care medicine.
[35] RudolfBerger,et al. B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002 .
[36] P G Katona,et al. Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. , 1975, Journal of applied physiology.
[37] J. Fleiss,et al. Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.
[38] D. Berman,et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] G. Parati,et al. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. , 1995, Hypertension.
[40] E F Cook,et al. Comparative Reproducibility and Validity of Systems for Assessing Cardiovascular Functional Class: Advantages of a New Specific Activity Scale , 1981, Circulation.